Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes

A Wilken, H Tawfik-Schlieper, KN Klotz and U Schwabe

Pharmakologisches Institut der Universitat Heidelberg, Heidelberg, Federal Republic of Germany.

Although adenosine is known to activate K+ conduction in atrial tissue, there is still debate as to the involvement of cAMP-dependent mechanisms. In isolated adult guinea pig atrial myocytes, we demonstrate that the highly A1-selective adenosine receptor agonist 2- chloro-N6-cyclopentyladenosine reduced basal cAMP levels by 30-40% in the absence and presence of the nonxanthine phosphodiesterase inhibitor Ro 20-1724. Isoprenaline caused a concentration-dependent increase in cAMP levels, which was more pronounced in the presence of the phosphodiesterase inhibitor. Several adenosine derivatives suppressed the isoprenaline-induced cAMP increase by approximately 80%. The rank order of potency was 2-chloro-N6-cyclopentyladenosine (IC50, 93 nM) greater than (R)-N6-phenylisopropyladenosine (IC50, 309 nM) greater than 5'-N-ethylcarboxamidoadenosine (IC50, 813 nM) much greater than (S)-N6-phenylisopropyladenosine (IC50, 26,300 nM). A similar but complete suppression of the isoprenaline-induced cAMP increase was produced by the muscarinic receptor agonist carbachol (IC50, 398 nM), which like adenosine is known to activate atrial K+ channels. The A1- adenosine receptor-selective antagonist 8-cyclopentyl-1,3- dipropylxanthine antagonized the effect of 2-chloro-N6- cyclopentyladenosine concentration-dependently, with a KB value of 9.6 nM. In atrial myocytes isolated from guinea pigs pretreated with pertussis toxin, the inhibitory effects of adenosine analogs on basal and isoprenaline-stimulated cAMP accumulation were markedly attenuated. It is concluded that the adenosine receptor in guinea pig atrial myocytes, which is known to be linked to K+ channels, is also coupled to adenylate cyclase via a pertussis toxin-sensitive guanine nucleotide- binding protein and shows the characteristics of the A1-adenosine receptor subtype.

Volume 37, Issue 6, pp. 916-920, 06/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. Varani, S. Merighi, S. Gessi, K.-N. Klotz, E. Leung, P. G. Baraldi, B. Cacciari, R. Romagnoli, G. Spalluto, and P. A. Borea [3H]MRE 3008F20: A Novel Antagonist Radioligand for the Pharmacological and Biochemical Characterization of Human A3 Adenosine Receptors Mol. Pharmacol., May 1, 2000; 57(5): 968 - 975. [Abstract] [Full Text]

				M. Srinivas, J. C. Shryock, D. M. Dennis, S. P. Baker, and L. Belardinelli Differential A1 Adenosine Receptor Reserve for Two Actions of Adenosine on Guinea Pig Atrial Myocytes Mol. Pharmacol., October 1, 1997; 52(4): 683 - 691. [Abstract] [Full Text]